Microbot Medical (MBOT) Competitors

Nano-X Imaging (NASDAQ:NNOX) and Microbot Medical (NASDAQ:MBOT) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking.

Does the MarketBeat Community favor NNOX or MBOT?

Microbot Medical received 315 more outperform votes than Nano-X Imaging when rated by MarketBeat users. However, 73.91% of users gave Nano-X Imaging an outperform vote while only 70.79% of users gave Microbot Medical an outperform vote.

Company	Underperform	Outperform
Nano-X Imaging	Outperform Votes 34 73.91%	Underperform Votes 12 26.09%
Microbot Medical	Outperform Votes 349 70.79%	Underperform Votes 144 29.21%

Do insiders and institutionals hold more shares of NNOX or MBOT?

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 5.4% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, NNOX or MBOT?

Nano-X Imaging has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500.

Is NNOX or MBOT more profitable?

Microbot Medical has a net margin of 0.00% compared to Nano-X Imaging's net margin of -465.38%. Nano-X Imaging's return on equity of -27.63% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-465.38%	-27.63%	-24.72%
Microbot Medical	N/A	-218.30%	-158.17%

Which has preferable earnings & valuation, NNOX or MBOT?

Microbot Medical has lower revenue, but higher earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$11.28M	26.12	-$60.78M	-$0.90	-5.67
Microbot Medical	N/A	N/A	-$10.74M	-$0.74	-2.81

Does the media favor NNOX or MBOT?

In the previous week, Nano-X Imaging had 5 more articles in the media than Microbot Medical. MarketBeat recorded 8 mentions for Nano-X Imaging and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.10 beat Nano-X Imaging's score of 0.29 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate NNOX or MBOT?

Nano-X Imaging presently has a consensus target price of $12.00, indicating a potential upside of 135.29%. Microbot Medical has a consensus target price of $9.00, indicating a potential upside of 332.69%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Nano-X Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Microbot Medical	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Nano-X Imaging beats Microbot Medical on 9 of the 16 factors compared between the two stocks.